Drugs and Treatment Resources
Featured Centers
- Top 10 Asthma Cities
- Health Check: How to Choose The Right Vitamins
- 10 Triggers for the Holiday Blues
CREON® 20
MINIMICROSPHERES®
(pancrelipase) Delayed-release Capsules, USP
CREON® 20 Capsules are orally administered and contain pancrelipase (lipase 20,000 USP Units, protease 75,000 USP Units and amylase 66,400 USP Units per capsule) which is of porcine pancreatic origin. Each CREON 20 Capsule is filled with 497 mg of delayed-release MINIMICROSPHERES®.
Inactive ingredients include dibutyl phthalate, dimethicone, hydroxypropylmethylcellulose phthalate, light mineral oil and polyethylene glycol. The capsule shells contain gelatin, red iron oxide, titanium dioxide and yellow iron oxide. The capsule imprinting ink contains dimethicone, 2-ethoxyethanol, shellac, soya lecithin, and titanium dioxide.
Last updated on RxList: 9/29/2008
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.
|
|